DAYTONA BEACH, Fla., March 8, 2017 /PRNewswire/ -- Germfree will introduce its Mobile Adaptive Bioproduction Suite on March 21, 2017 at International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical, biotechnology and device innovation, technology and knowledge from development through commercialization. This adaptive cleanroom trailer is the first of its kind to provide configurable space for cGMP production, R&D and biocontainment within a self-contained mobile platform. Accelerated innovation in the biopharmaceutical industry has generated a shift toward more flexible manufacturing environments. The Bioproduction Suite is a new approach for rapid deployment of cleanrooms and adaptable platforms for bioprocessing. INTERPHEX takes place March 21-23, 2017 at the Jacob Javits Center in New York, New York.
The 53' (16 meter) stand-alone cGMP facility will be featured as a special event at INTERPHEX 2017. "INTERPHEX offers the ideal venue to demonstrate technologies that represent the future of pharmaceutical and biologics development and production," said Melissa Ashley, Senior Vice President, INTERPHEX. "We are delighted that Germfree will exhibit a mobile adaptive bioproduction suite for attendees to walk through and experience solutions that maximize onsite space and offer personnel safety and containment control in a self-contained platform right on the show floor."
Adaptive Bioproduction Suites are configured to meet the specific technical and validation requirements for each application. The units are ideally suited to adjust for emerging biopharmaceutical processes as they utilize Germfree's interchangeable casework and laminar flow equipment. The Bioproduction Suite will be presented as a concept cleanroom facility. Specialty bioprocessing equipment will be integrated from many exhibiting partners including: Eppendorf, Getinge, Rotronic Instrument Corporation, STERIS, Thermo Fisher Scientific, Carltex, BMT USA and TSI Inc.
"The pharmaceutical industry is under intense pressure to adapt production processes and facilities that keep up with the rapid pace of innovation." said Jeff Serle, Senior VP, Germfree. "We've developed the Adaptive Bioproduction Suite to provide the next level of flexibility. It was also critical for our platform to be engineered as a self-contained, stand-alone facility that can be easily repurposed and relocated anywhere in the world."
Germfree's Adaptive Bioproduction Suites are optimal for a wide range of biopharmaceutical production applications including: monoclonal antibodies, therapeutic proteins, gene therapy, viral vector and live virus vaccines. Adaptive trailers offer flexible cleanroom space that is easily configured to required ISO grades as well as biological safety levels up to BSL-3. These capabilities help facilitate the rapid development and clinical trial manufacturing processes that are critical to product pipeline success.
"The Adaptive Trailers provide new options for fast and flexible cGMP/biocontainment production space that would be impractical in a brick and mortar building." said Carol Houts, Director of Quality, Germfree. "These units will also allow biotechnology companies to solve small scale processing challenges especially for precision medicine." Germfree's technology will be demonstrated, together with product innovations from participating partner vendors.
Additional Information: www.germfree.com/pr/interphex-2017/
Germfree manufactures advanced cGMP-compliant mobile and modular bioproduction and biocontainment platforms. The company was established in 1962 to provide aseptic control and biosafety for institutions ranging from hospital pharmacies to high containment laboratories. Today, Germfree's BSL-3 labs are deployed globally to meet the rigorous demands of military and public health agencies.
This extensive experience has positioned Germfree to build cleanroom platforms, which exceed the engineering standards of traditional facilities. Our leading-edge fabrication technology, engineering teams and subject-matter experts are located at our 140,000 square-foot (13,000 square-meter) US manufacturing plant. For more information, visit www.germfree.com.
For the past 38 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can "Experience Science through Commercialization." Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 11,500 global industry professionals and 625+ industry leading suppliers together to "Learn it, Experience it, Procure it" through a unique combination of no cost technical conference, exhibits, demonstrations, workshops, partnering opportunities and networking to leverage quality, efficiency and cost effectiveness in today's ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. For more information, visit www.INTERPHEX.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/first-adaptive-bioproduction-suite-to-debut-at-premier-biopharma-event-300420437.html